SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-118527
Filing Date
2014-03-27
Accepted
2014-03-27 16:07:01
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d657912d10k.htm 10-K 1096576
2 EX-21.1 d657912dex211.htm EX-21.1 1654
3 EX-23.1 d657912dex231.htm EX-23.1 1304
4 EX-31.1 d657912dex311.htm EX-31.1 5863
5 EX-31.2 d657912dex312.htm EX-31.2 5803
6 EX-32.1 d657912dex321.htm EX-32.1 4288
7 GRAPHIC g657912g30v90.jpg GRAPHIC 54074
8 GRAPHIC g657912g31d08.jpg GRAPHIC 49524
9 GRAPHIC g657912g32c94.jpg GRAPHIC 25719
10 GRAPHIC g657912g40e60.jpg GRAPHIC 37237
11 GRAPHIC g657912g43l53.jpg GRAPHIC 28663
12 GRAPHIC g657912g47t84.jpg GRAPHIC 49922
13 GRAPHIC g657912g63h35.jpg GRAPHIC 50152
14 GRAPHIC g657912g88t77.jpg GRAPHIC 40689
  Complete submission text file 0001193125-14-118527.txt   1580608
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36281 | Film No.: 14721671
SIC: 2834 Pharmaceutical Preparations